News Center_Information Center_ Shanghai Chenguang Medical Technology Co., Ltd.

Information Center

Wen Wei Po published "C&G Medical breaks international monopoly ......"
Wen Wei Po published "C&G Medical breaks international monopoly ......"
By Ye Songting In recent times, several global multinational companies producing core components of MRI equipment are a bit nervous because local Chinese companies are beginning to call their bluff, and one of them is Shanghai Centron Medical Technology Co. This seemingly infamous local company has broken the GPS (General Electric, Philips, Siemens) "triumvirate" of MRI system key components "magnetic resonance coil" (i.e. RF detector) for many years in the previous 10 years. This has helped domestic medical institutions save a lot of money. "We have drilled deep into the MRI coil market, and it's time to enter other related segments of the industry chain." Wang Jie, chairman of the company, said that the new research team will be assembled soon, and the "charge" will be blown within the year.  The "returnee" boss monthly salary of 800 yuan back in 2004, when MRI equipment has begun to gradually popularize in domestic hospitals, but whether the machine or parts, most of the "three giants" monopoly, local enterprises in this field almost a blank. The local enterprises in this field were almost blank. After completing his PhD in Japan and working in the United States for several years, Wang Jie decided to return to China because of a phone call from a fellow student at Fudan. Leaving his wife and children with a sum of money for living expenses, he flew back to Shanghai with all his savings of $30,000 and lived in a three-room apartment lent to him by his senior brother, which turned out to be a small living room that became Tatsunoko's initial office. "I lived in one room, stuffed all the remaining furniture into the other room, and then converted the vacated living room into a laboratory." The lab was soon up and running, but $30,000 was almost spent because the company was engaged in magnetic resonance coil research and development abroad. There were only five people in the company, three doctors, one technician and one administrative manager. In order to save money, we had to order 5 box lunches at noon for $5. The general manager was paid $800 per month, the administrative manager $600, and the highest income was the R&D director, who was paid $3000 per month. Because only expenses without income, and persist for a while, the company is about to "run out of money". At this time, the Municipal Science and Technology Commission funded 500,000 yuan of scientific research, and the Municipal Food and Drug Administration, which could not find the industry classification in the medical equipment catalog, completed all the procedures in eight months and helped the company get the Medical Device Manufacturer License and the Medical Device Registration Certificate. "I have inquired, if the company does not land in Shanghai, slowly go through the process may have to wait a year and a half." Wang Jie said. With the money, the license, and the contacts and influence accumulated abroad, the company finally pulled in its first order: four coils designed for customers, with a design fee of $250,000.  Drill into the "blue ocean" to engage in scientific research After passing the "life and death crisis", the company will invest a lot of resources in new product development. Zhang Songtao, director of research and development, said that there are two general directions of research and development: one is to optimize existing products, reduce costs or improve performance. Centron had designed a joint head and neck coil, before the "Big Three" monopoly market, similar products sold for about 1 million yuan each. After Centron's product was introduced, its performance was similar but it was sold for about 300,000 yuan, forcing the "Big Three" to lower the price to less than 400,000 yuan. For MRI machines, the coils are "semi-consumable" and may be damaged and need to be replaced after a period of time, so Centron's "catfish" has helped domestic medical institutions save a lot of money on equipment. Another more important direction is to "tailor" new products to market gaps and the needs of medical institutions. They previously heard customers complaining that nowadays there are more and more cardiovascular and cerebrovascular diseases, and the carotid artery has become an "accident-prone place", but there has been no coil specifically for the carotid artery on the market, and hospitals can only use neck coils or combined head and neck coils instead, but the clarity is not high. Finding this "blue ocean", C&G jumped in and soon developed a carotid artery coil, with a key indicator "signal-to-noise ratio" about three times higher than that of other alternative coils, which means doctors can see capillaries and early lesions more clearly. Relying on the product's cost performance and technical advantages, Centron has obtained 69 patents in recent years, and its business data has shown "exponential" growth: the annual output value of 10 million yuan in 2008 reached 83 million yuan in 2012, and is expected to hit 100 milli
See More
By Ye Songting In recent times, several global multinational companies producing core components of MRI equipment are a bit nervous because local Chinese companies are beginning to call their bluff, and one of them is Shanghai Centron Medical Technology Co. This seemingly infamous local company has broken the GPS (General Electric, Philips, Siemens) "triumvirate" of MRI system key components "magnetic resonance coil" (i.e. RF detector) for many years in the previous 10 years. This has helped domestic medical institutions save a lot of money. "We have drilled deep into the MRI coil market, and it's time to enter other related segments of the industry chain." Wang Jie, chairman of the company, said that the new research team will be assembled soon, and the "charge" will be blown within the year.  The "returnee" boss monthly salary of 800 yuan back in 2004, when MRI equipment has begun to gradually popularize in domestic hospitals, but whether the machine or parts, most of the "three giants" monopoly, local enterprises in this field almost a blank. The local enterprises in this field were almost blank. After completing his PhD in Japan and working in the United States for several years, Wang Jie decided to return to China because of a phone call from a fellow student at Fudan. Leaving his wife and children with a sum of money for living expenses, he flew back to Shanghai with all his savings of $30,000 and lived in a three-room apartment lent to him by his senior brother, which turned out to be a small living room that became Tatsunoko's initial office. "I lived in one room, stuffed all the remaining furniture into the other room, and then converted the vacated living room into a laboratory." The lab was soon up and running, but $30,000 was almost spent because the company was engaged in magnetic resonance coil research and development abroad. There were only five people in the company, three doctors, one technician and one administrative manager. In order to save money, we had to order 5 box lunches at noon for $5. The general manager was paid $800 per month, the administrative manager $600, and the highest income was the R&D director, who was paid $3000 per month. Because only expenses without income, and persist for a while, the company is about to "run out of money". At this time, the Municipal Science and Technology Commission funded 500,000 yuan of scientific research, and the Municipal Food and Drug Administration, which could not find the industry classification in the medical equipment catalog, completed all the procedures in eight months and helped the company get the Medical Device Manufacturer License and the Medical Device Registration Certificate. "I have inquired, if the company does not land in Shanghai, slowly go through the process may have to wait a year and a half." Wang Jie said. With the money, the license, and the contacts and influence accumulated abroad, the company finally pulled in its first order: four coils designed for customers, with a design fee of $250,000.  Drill into the "blue ocean" to engage in scientific research After passing the "life and death crisis", the company will invest a lot of resources in new product development. Zhang Songtao, director of research and development, said that there are two general directions of research and development: one is to optimize existing products, reduce costs or improve performance. Centron had designed a joint head and neck coil, before the "Big Three" monopoly market, similar products sold for about 1 million yuan each. After Centron's product was introduced, its performance was similar but it was sold for about 300,000 yuan, forcing the "Big Three" to lower the price to less than 400,000 yuan. For MRI machines, the coils are "semi-consumable" and may be damaged and need to be replaced after a period of time, so Centron's "catfish" has helped domestic medical institutions save a lot of money on equipment. Another more important direction is to "tailor" new products to market gaps and the needs of medical institutions. They previously heard customers complaining that nowadays there are more and more cardiovascular and cerebrovascular diseases, and the carotid artery has become an "accident-prone place", but there has been no coil specifically for the carotid artery on the market, and hospitals can only use neck coils or combined head and neck coils instead, but the clarity is not high. Finding this "blue ocean", C&G jumped in and soon developed a carotid artery coil, with a key indicator "signal-to-noise ratio" about three times higher than that of other alternative coils, which means doctors can see capillaries and early lesions more clearly. Relying on the product's cost performance and technical advantages, Centron has obtained 69 patents in recent years, and its business data has shown "exponential" growth: the annual output value of 10 million yuan in 2008 reached 83 million yuan in 2012, and is expected to hit 100 milli
Construction of "High Sensitivity Magnetic Resonance RF Detector Production and R&D Base Construction Project" started
Construction of "High Sensitivity Magnetic Resonance RF Detector Production and R&D Base Construction Project" started
        Ltd. "High Sensitivity Magnetic Resonance RF Detector Production and R&D Base Construction Project" has been actively prepared and coordinated by the company's leaders, and has obtained various administrative approval documents and met the requirements for starting the construction. All the employees of the company held a grand groundbreaking ceremony on August 21 at the base site, and Dr. Wang Jie, the chairman of the board, delivered the groundbreaking speech, marking the official start of the project, which is expected to be completed and put into operation in the second half of 2013. The completion of the project will greatly enhance the R&D and production capacity of Centron Medical's "High Sensitivity Magnetic Resonance RF Detector" and further improve its market competitiveness.
See More
        Ltd. "High Sensitivity Magnetic Resonance RF Detector Production and R&D Base Construction Project" has been actively prepared and coordinated by the company's leaders, and has obtained various administrative approval documents and met the requirements for starting the construction. All the employees of the company held a grand groundbreaking ceremony on August 21 at the base site, and Dr. Wang Jie, the chairman of the board, delivered the groundbreaking speech, marking the official start of the project, which is expected to be completed and put into operation in the second half of 2013. The completion of the project will greatly enhance the R&D and production capacity of Centron Medical's "High Sensitivity Magnetic Resonance RF Detector" and further improve its market competitiveness.
The vice mayor of Qingpu District and other leaders came to visit our project site in Qingpu
The vice mayor of Qingpu District and other leaders came to visit our project site in Qingpu
        At 14:00 on December 26, 2012, Ms. Sun Ping, Standing Committee Member and Vice Mayor of Qingpu District, Shanghai, Mr. Xiao Guimin, General Manager of Shanghai Zhangjiang Hi-Tech Industrial Development Zone Qingpu Park Co. Ltd. and accompanied by Mr. Wang Jie, Chairman of Shanghai Centron Medical Technology Co. After listening to the work report of Mr. Wang Jie, Vice Mayor Sun spoke highly of the Qingpu project. At the same time, he said that the government of Qingpu District will strongly support the work of the settled enterprises, establish a "green channel" for the development of enterprises, provide "one-stop" quick service for enterprises, and focus on solving the problems of land, raw materials, manpower, capital, electricity and other factors for the development of enterprises. The problem. Especially for high-tech enterprises with high development orientation, high market potential and independent innovation like Centron.

See More
        At 14:00 on December 26, 2012, Ms. Sun Ping, Standing Committee Member and Vice Mayor of Qingpu District, Shanghai, Mr. Xiao Guimin, General Manager of Shanghai Zhangjiang Hi-Tech Industrial Development Zone Qingpu Park Co. Ltd. and accompanied by Mr. Wang Jie, Chairman of Shanghai Centron Medical Technology Co. After listening to the work report of Mr. Wang Jie, Vice Mayor Sun spoke highly of the Qingpu project. At the same time, he said that the government of Qingpu District will strongly support the work of the settled enterprises, establish a "green channel" for the development of enterprises, provide "one-stop" quick service for enterprises, and focus on solving the problems of land, raw materials, manpower, capital, electricity and other factors for the development of enterprises. The problem. Especially for high-tech enterprises with high development orientation, high market potential and independent innovation like Centron.

Shanghai C&G was awarded the title of "Shanghai 2012 Small Giant Cultivating Enterprise".
Shanghai C&G was awarded the title of "Shanghai 2012 Small Giant Cultivating Enterprise".
On September 4, 2012, the website of Shanghai Science and Technology Commission announced the latest "2012 Shanghai Science and Technology Small Giant Project Proposed Project Announcement List", in which Shanghai Centron Medical Technology Co. In order to promote the independent innovation of science and technology enterprises, Shanghai implemented the Small Giant Project, aiming to create small giant enterprises with competitive advantages in the industry at home and abroad. With its perfect innovation mechanism, strong investment in scientific research and steady growth, Centron Medical became the 2012 Small Giant Incubatees of Shanghai, and obtained the financial support from Shanghai Science and Technology Commission.

See More
On September 4, 2012, the website of Shanghai Science and Technology Commission announced the latest "2012 Shanghai Science and Technology Small Giant Project Proposed Project Announcement List", in which Shanghai Centron Medical Technology Co. In order to promote the independent innovation of science and technology enterprises, Shanghai implemented the Small Giant Project, aiming to create small giant enterprises with competitive advantages in the industry at home and abroad. With its perfect innovation mechanism, strong investment in scientific research and steady growth, Centron Medical became the 2012 Small Giant Incubatees of Shanghai, and obtained the financial support from Shanghai Science and Technology Commission.

Previous page
1
2
16

Copyright   上海辰光医疗科技股份有限公司     沪ICP备08006789号-7  技术支持:中企动力   上海